- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech Blue chip stocks
U.S. Pharmaceuticals & Biotech Blue chip stocks
Results
19
1 new
19 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
ILMN | US$144.36 | 3.0% | 31.5% | US$22.9b | US$164.60 | PS5.2x | E70.4% | 2.2% | ||
KRTX | US$329.83 | 3.3% | 80.7% | US$12.6b | US$326.92 | PS19238.9x | E60.1% | n/a | ||
VRTX | US$464.56 | 3.0% | 32.3% | US$119.6b | US$514.81 | PS11.3x | E47.4% | n/a | ||
HZNP | US$116.30 | 0.06% | 82.8% | US$26.6b | US$116.50 | PE60.8x | E16.4% | n/a | ||
ALNY | US$253.74 | 3.6% | 48.0% | US$32.7b | US$298.77 | PS15.6x | E70.3% | n/a | ||
EXAS New | US$61.69 | 16.6% | -8.0% | US$11.4b | US$70.81 | PS4.2x | E72.4% | n/a | ||
TECH | US$75.38 | 5.8% | 16.7% | US$12.0b | US$85.25 | PE79.5x | E21.2% | 0.4% | ||
VTRS | US$13.22 | -1.1% | 41.1% | US$15.8b | US$13.33 | PS1x | E51.6% | 3.6% | ||
BGNE | US$206.16 | 8.2% | 10.0% | US$21.9b | US$280.06 | PS6.8x | E73.2% | n/a | ||
SRPT | US$137.94 | 20.8% | 63.4% | US$13.2b | US$183.82 | PE108.1x | E42.5% | n/a | ||
ABBV | US$183.08 | 3.5% | 27.7% | US$323.5b | US$204.74 | PE63.7x | E28.1% | 3.6% | ||
LLY | US$788.19 | 5.4% | 35.0% | US$709.7b | US$992.18 | PE84.8x | E29.2% | 0.7% | ||
BMRN | US$65.42 | 1.8% | -29.2% | US$12.5b | US$98.02 | PE38.7x | E27.2% | n/a | ||
MEDP | US$338.96 | 0.4% | 23.1% | US$10.5b | US$347.92 | PE28.8x | E10.7% | n/a | ||
BMY | US$59.27 | 0.7% | 18.3% | US$120.2b | US$59.64 | PS2.5x | E49.9% | 4.0% | ||
INCY | US$75.45 | 5.2% | 39.7% | US$14.5b | US$78.31 | PE447.5x | E46.5% | n/a | ||
GILD | US$92.41 | 2.5% | 19.0% | US$115.2b | US$97.20 | PE914x | E40.6% | 3.3% | ||
NBIX | US$126.59 | 0.7% | 8.1% | US$12.8b | US$163.46 | PE33.2x | E29.6% | n/a | ||
MRK | US$103.12 | 4.0% | -0.3% | US$260.9b | US$130.89 | PE21.5x | E15.6% | 3.1% |
Page 1 of 1